6-(6-METHOXY-5-(4-METHYL-1H-IMIDAZOL-1-YL)PYRIDIN-2-YL)-4-METHYL-N-(1-(2,4,6-TRIFLUOROPHENYL)ETHYL)PYRIDAZIN-3-AMINE, (S)-
UNII 88Q3S6E5KA
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-(6-methoxy-5-(4-methyl-1h-imidazol-1-yl)pyridin-2-yl)-4-methyl-n-(1-(2,4,6-trifluorophenyl)ethyl)pyridazin-3-amine, (s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 88Q3S6E5KA.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1914990-18-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H21F3N6O IQOIKKNNMIIPNH-AWEZNQCLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-(6-methoxy-5-(4-methyl-1h-imidazol-1-yl)pyridin-2-yl)-4-methyl-n-(1-(2,4,6-trifluorophenyl)ethyl)pyridazin-3-amine, (s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.